BIAF 1.37 (+3.79%)
US09076W1099Medical Diagnostics & ResearchDiagnostics & Research

BioAffinity Technologies (BIAF) Competitor Comparison

We are evaluating the key criteria listed to compare BioAffinity Technologies (BIAF) against its competitors in the Diagnostics & Research industry.

Gross Profits - BIAF ranking 0 / 52

These are the competitors of BioAffinity Technologies in the industry Diagnostics & Research ranked by gross profits
1. Thermo Fisher Scientific TMO
19B
2. Danaher DHR
18.95B
3. IQVIA Holdings IQV
5.03B
4. Laboratory Corp of America Holdings LH
4.39B
5. Quest Diagnostics DGX
3.47B
6. Agilent Technologies A
3.47B
7. Illumina ILMN
3.15B
8. Mettler-Toledo MTD
2.31B
9. Icon ICLR
2.22B
10. PerkinElmer PKI
2.04B
11. IDEXX Laboratories IDXX
2B
12. DexCom DXCM
1.88B
13. Waters WAT
1.72B
14. Exact Sciences EXAS
1.51B
15. Charles River Laboratories CRL
1.46B
16. Qiagen QGEN
1.44B
17. Syneos Health SYNH
1.25B
18. Ortho Clinical Diagnostics Holdings OCDX
1.04B
19. Medpace Holdings MEDP
925.11M
20. Lantheus Holdings LNTH
581.7M
21. Sotera Health SHC
557M
22. Myriad Genetics MYGN
476.4M
23. Neogen NEOG
409.2M
24. Fulgent Genetics FLGT
366.9M
25. Natera NTRA
363.97M
26. Guardant Health GH
293.21M
27. RadNet RDNT
288.77M
28. CareDx CDNA
209.58M
29. Meridian Bioscience VIVO
188.36M
30. NeoGenomics NEO
187.9M
31. Inotiv NOTV
157.21M
32. Global Cord Blood CO
147.48M
33. Prenetics Global PRE
131.55M
34. Heska HSKA
111.17M
35. National Research NRC
94.52M
36. Olink Holding OLK
94.5M
37. Twist Bioscience TWST
84.24M
38. Pacific Biosciences of California PACB
53.47M
39. Neuronetics STIM
49.72M
40. MaxCyte MXCT
39.16M
41. Co-Diagnostics CODX
28.74M
42. Biodesix BDSX
24.06M
43. Exagen XGN
21.35M
44. MDxHealth MDXH
19.22M
45. Interpace Biosciences IDXG
18.23M
46. DarioHealth DRIO
14.01M
47. Personalis PSNL
13.35M
48. Enzo Biochem ENZ
11.57M
49. Aspira Womens Health AWH
4.32M
50. SeqLL SQL
77.97K
51. Sera Prognostics SERA
75K
52. Organovo Holdings ONVO
-8.52M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.